Abstract
PTCH1 and SUFU are both regulators of the sonic hedgehog signalling pathway. Germline inactivating mutations in both genes are associated with multisystem phenotypes including medulloblastoma. Somatic inactivating mutations in PTCH1 and SUFU each occur in approximately 10% of medulloblastomas. Recently, SUFU mutations were reported in familial medulloblastoma pedigrees without additional phenotypic features. We sought to further investigate the contribution of germline PTCH1 and SUFU mutations to familial and sporadic medulloblastoma. We performed full-gene mutational analysis of both PTCH1 and SUFU in three familial medulloblastoma pedigrees and 83 individuals with sporadic non-familial medulloblastoma. We identified no mutations in PTCH1 or SUFU in the three familial medulloblastoma pedigrees. We identified no PTCH1 mutations and two SUFU mutations that cause premature protein truncating in the series of sporadic non-familial medulloblastomas. The SUFU mutations were identified in two of the 16 individuals with desmoplastic medulloblastomas. These data indicate that familial medulloblastoma is a genetically heterogeneous disorder with at least one further susceptibility gene to be discovered. Furthermore, although both PTCH1 and SUFU play a key role in the sonic hedgehog signalling pathway, PTCH1 does not make an appreciable contribution to non-familial sporadic medulloblastoma, whereas inactivating germline mutations of SUFU cause ~2–3% of sporadic medulloblastomas and > 10% of desmoplastic medulloblastomas.
Similar content being viewed by others
Abbreviations
- MBEN:
-
Medulloblastoma with extensive nodularity
- NBCCS:
-
Nevoid basal cell carcinoma syndrome
- CCLG:
-
Children’s cancer and leukaemia group
- PCR:
-
Polymerase chain reaction
References
Pfister S, Hartmann C, Korshunov A (2009) Histology and molecular pathology of pediatric brain tumors. J Child Neurol 24(11):1375–1386
Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109
Rousseau A, Mokhtari K, Duyckaerts C (2008) The 2007 WHO classification of tumors of the central nervous system—what has changed? Curr Opin Neurol 21(6):720–727
McManamy CS, Pears J, Weston CL et al (2007) Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 17(2):151–164
Cowan R, Hoban P, Kelsey A, Birch JM, Gattamaneni R, Evans DG (1997) The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer 76(2):141–145
Amlashi SF, Riffaud L, Brassier G, Morandi X (2003) Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 98(3):618–624
Zurawel RH, Allen C, Chiappa S et al (2000) Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosomes Cancer 27(1):44–51
Taylor MD, Liu L, Raffel C et al (2002) Mutations in SUFU predispose to medulloblastoma. Nat Genet 31(3):306–310
Pastorino L, Ghiorzo P, Nasti S et al (2009) Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A 149A(7):1539–1543
Moschovi M, Sotiris Y, Prodromou N et al (1998) Familial medulloblastoma. Pediatr Hematol Oncol 15(5):421–424
von Koch CS, Gulati M, Aldape K, Berger MS (2002) Familial medulloblastoma: case report of one family and review of the literature. Neurosurgery 51(1): 227–233 (discussion 33)
Brugieres L, Pierron G, Chompret A et al (2010) Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. J Med Genet 47(2):142–144
Pasca di Magliano M, Hebrok M (2003) Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 3(12):903–911
Toftgard R (2000) Hedgehog signalling in cancer. Cell Mol Life Sci 57(12):1720–1731
Rubin JB, Rowitch DH (2002) Medulloblastoma: a problem of developmental biology. Cancer Cell 2(1):7–8
Entz-Werle N, Carli ED, Ducassou S, Legrain M, Grill J, Dufour C (2008) Medulloblastoma: what is the role of molecular genetics? Expert Rev Anticancer Ther 8(7):1169–1181
Crawford JR, MacDonald TJ, Packer RJ (2007) Medulloblastoma in childhood: new biological advances. Lancet Neurol 6(12):1073–1085
Ellison D (2002) Classifying the medulloblastoma: insights from morphology and molecular genetics. Neuropathol Appl Neurobiol 28(4):257–282
Brenner DJ, Quan H (1990) Exact confidence limits for binomial proportions—Pearson and Hartley revisited. Statistician 39:391–397
Kimonis VE, Goldstein AM, Pastakia B et al (1997) Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69(3):299–308
Ng D, Stavrou T, Liu L et al (2005) Retrospective family study of childhood medulloblastoma. Am J Med Genet A 134(4):399–403
Acknowledgments
We thank the children and families involved in the research and the physicians, nurses and pathologists who referred families and provided samples. We thank Nikki Huxter, Margaret Warren-Perry, Darshna Dudakia, Polly Gibbs, Jessie Bull and Anna Zachariou for assistance of recruitment. We thank Bernadette Ebbs and Deborah Hughes for running the ABI sequencers. The research was carried out as part of the Factors Associated with Childhood Tumors (FACT) study, which is a UK Children’s Cancer and Leukaemia Group (CCLG) study. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health and the Scottish Ministers. I.S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme. We acknowledge NHS funding to the NIHR Biomedical Research Centre. This work was supported by Cancer Research UK (grants C8620_A9024 and C8620_A8857) and the Institute of Cancer Research (UK).
Conflict of interest
None to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Accession numbers: The cDNA Genbank accession number for the PTCH1 sequence reported in this paper is NM_000264 and for the SUFU sequence reported in this paper is NM_016169.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Slade, I., Murray, A., Hanks, S. et al. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Familial Cancer 10, 337–342 (2011). https://doi.org/10.1007/s10689-010-9411-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-010-9411-0